Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability
Advanced Science · 2024-10 · 11 (38)
DOI: 10.1002/advs.202403473 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Science, online erschienen am 05.08.2024. Verfasst von Qingting Song und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The Chinese University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Blood-Brain Barrier, Nanostructures, Drug Delivery Systems. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 370 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Hong Kong Research Grant Council, The Chinese University of Hong Kong.
Themen: Demenz
Abstract (Originalsprache)
As a form of dementia, Alzheimer's disease (AD) suffers from no efficacious cure, yet AD treatment is still imperative, as it ameliorates the symptoms or prevents it from deteriorating or maintains the current status to the longest extent. The human brain is the most sensitive and complex organ in the body, which is protected by the blood–brain barrier (BBB). This yet induces the difficulty in curing AD as the drugs or nanomaterials that are much inhibited from reaching the lesion site. Thus, BBB crossing capability of drug delivery system remains a significant challenge in the development of neurological therapeutics. Fortunately, nano‐enabled delivery systems possess promising potential to achieve multifunctional diagnostics/therapeutics against various targets of AD owing to their intriguing advantages of nanocarriers, including easy multifunctionalization on surfaces, high surface‐to‐volume ratio with large payloads, and potential ability to cross the BBB, making them capable of conquering the limitations of conventional drug candidates. This review, which focuses on the BBB crossing ability of the multifunctional nanomaterials in AD diagnosis and treatment, will provide an insightful vision that is conducive to the development of AD‐related nanomaterials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chemistry, The Chinese University of Hong Kong, Hong Kong, China.
ORCID-Profile: Hung-Wing Li
Förderung
- The Hong Kong Research Grant Council
- The Chinese University of Hong Kong
Zitieren
APA
Song, Q., Li, J., Li, T., & Li, H. W. (2024). Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability. Advanced Science, 11(38). https://doi.org/10.1002/advs.202403473
Vancouver
Song Q, Li J, Li T, Li HW. Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability. Advanced Science. 2024;11(38). doi:10.1002/advs.202403473
BibTeX
@article{Song2024,
author = {Song, Qingting and Li, Junyou and Li, Ting and Li, Hung-Wing},
title = {Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {38},
doi = {10.1002/advs.202403473}
}
EUVIMED